These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37429030)

  • 1. Risk for Chronic Kidney Disease Progression After Acute Kidney Injury: Findings From the Chronic Renal Insufficiency Cohort Study.
    Muiru AN; Hsu JY; Zhang X; Appel LJ; Chen J; Cohen DL; Drawz PE; Freedman BI; Go AS; He J; Horwitz EJ; Hsu RK; Lash JP; Liu KD; McCoy IE; Porter A; Rao P; Ricardo AC; Rincon-Choles H; Sondheimer J; Taliercio J; Unruh M; Hsu CY;
    Ann Intern Med; 2023 Jul; 176(7):961-968. PubMed ID: 37429030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Association of Intraindividual Difference Between Cystatin- and Creatinine-Based Estimated GFR and Contrast-Associated Acute Kidney Injury.
    Zhang LW; Luo MQ; Zeng JL; You ZB; Chen LC; Chen JH; Lin KY; Guo YS
    Clin Interv Aging; 2024; 19():411-420. PubMed ID: 38476830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Intraindividual Difference in Estimated Glomerular Filtration Rate by Creatinine vs Cystatin C and End-stage Kidney Disease and Mortality.
    Chen DC; Shlipak MG; Scherzer R; Bauer SR; Potok OA; Rifkin DE; Ix JH; Muiru AN; Hsu CY; Estrella MM
    JAMA Netw Open; 2022 Feb; 5(2):e2148940. PubMed ID: 35175342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Intra-individual Differences in Estimated GFR by Creatinine Versus Cystatin C With Incident Heart Failure.
    Chen DC; Shlipak MG; Scherzer R; Bansal N; Potok OA; Rifkin DE; Ix JH; Muiru AN; Hsu CY; Estrella MM
    Am J Kidney Dis; 2022 Dec; 80(6):762-772.e1. PubMed ID: 35817274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers During Recovery From AKI and Prediction of Long-term Reductions in Estimated GFR.
    Wilson M; Packington R; Sewell H; Bartle R; McCole E; Kurth MJ; Richardson C; Shaw S; Akani A; Banks RE; Selby NM
    Am J Kidney Dis; 2022 May; 79(5):646-656.e1. PubMed ID: 34653541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of the 2021 Race-Free CKD-EPI Creatinine- and Cystatin C-Based Estimated GFR Equations Among Kidney Transplant Recipients.
    Hundemer GL; White CA; Norman PA; Knoll GA; Tangri N; Sood MM; Hiremath S; Burns KD; McCudden C; Akbari A
    Am J Kidney Dis; 2022 Oct; 80(4):462-472.e1. PubMed ID: 35588905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical utility and cost impact of cystatin C measurement in the diagnosis and management of chronic kidney disease: A primary care cohort study.
    Shardlow A; McIntyre NJ; Fraser SDS; Roderick P; Raftery J; Fluck RJ; McIntyre CW; Taal MW
    PLoS Med; 2017 Oct; 14(10):e1002400. PubMed ID: 29016597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Creatinine- and cystatin C-based estimated glomerular filtration rate slopes for the prediction of kidney outcome: a comparative retrospective study.
    Kim S; Hwang S; Jang HR; Sohn I; Ahn HS; Park HD; Huh W; Jin DC; Kim YG; Kim DJ; Oh HY; Lee JE
    BMC Nephrol; 2019 Jun; 20(1):214. PubMed ID: 31185945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystatin C- and creatinine-based estimated glomerular filtration rate, vascular disease, and mortality in persons with diabetes in the U.S.
    Tsai CW; Grams ME; Inker LA; Coresh J; Selvin E
    Diabetes Care; 2014 Apr; 37(4):1002-8. PubMed ID: 24271191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Estimated GFR Calculated Using Race-Free Equations With Kidney Failure and Mortality by Black vs Non-Black Race.
    Gutiérrez OM; Sang Y; Grams ME; Ballew SH; Surapaneni A; Matsushita K; Go AS; Shlipak MG; Inker LA; Eneanya ND; Crews DC; Powe NR; Levey AS; Coresh J;
    JAMA; 2022 Jun; 327(23):2306-2316. PubMed ID: 35667006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Black and White Adults With CKD Hospitalized With Acute Kidney Injury: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Muiru AN; Yang J; Derebail VK; Liu KD; Feldman HI; Srivastava A; Bhat Z; Saraf SL; Chen TK; He J; Estrella MM; Go AS; Hsu CY;
    Am J Kidney Dis; 2022 Nov; 80(5):610-618.e1. PubMed ID: 35405207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Cystatin C Level for Risk Stratification in Adults With Chronic Kidney Disease.
    Lees JS; Rutherford E; Stevens KI; Chen DC; Scherzer R; Estrella MM; Sullivan MK; Ebert N; Mark PB; Shlipak MG
    JAMA Netw Open; 2022 Oct; 5(10):e2238300. PubMed ID: 36282503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute Kidney Injury Recovery Pattern and Subsequent Risk of CKD: An Analysis of Veterans Health Administration Data.
    Heung M; Steffick DE; Zivin K; Gillespie BW; Banerjee T; Hsu CY; Powe NR; Pavkov ME; Williams DE; Saran R; Shahinian VB;
    Am J Kidney Dis; 2016 May; 67(5):742-52. PubMed ID: 26690912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Acute Kidney Injury and Longitudinal Kidney Function After Hospital Discharge Among Patients With and Without COVID-19.
    Nugent J; Aklilu A; Yamamoto Y; Simonov M; Li F; Biswas A; Ghazi L; Greenberg H; Mansour G; Moledina G; Wilson FP
    JAMA Netw Open; 2021 Mar; 4(3):e211095. PubMed ID: 33688965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-Acute Kidney Injury Proteinuria and Subsequent Kidney Disease Progression: The Assessment, Serial Evaluation, and Subsequent Sequelae in Acute Kidney Injury (ASSESS-AKI) Study.
    Hsu CY; Chinchilli VM; Coca S; Devarajan P; Ghahramani N; Go AS; Hsu RK; Ikizler TA; Kaufman J; Liu KD; Parikh CR; Reeves WB; Wurfel M; Zappitelli M; Kimmel PL; Siew ED;
    JAMA Intern Med; 2020 Mar; 180(3):402-410. PubMed ID: 31985750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in the prevalence of reduced GFR in the United States: a comparison of creatinine- and cystatin C-based estimates.
    Grams ME; Juraschek SP; Selvin E; Foster MC; Inker LA; Eckfeldt JH; Levey AS; Coresh J
    Am J Kidney Dis; 2013 Aug; 62(2):253-60. PubMed ID: 23619125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Difference Between Cystatin C- and Creatinine-Based Estimated GFR and Associations With Frailty and Adverse Outcomes: A Cohort Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT).
    Potok OA; Ix JH; Shlipak MG; Katz R; Hawfield AT; Rocco MV; Ambrosius WT; Cho ME; Pajewski NM; Rastogi A; Rifkin DE
    Am J Kidney Dis; 2020 Dec; 76(6):765-774. PubMed ID: 32682697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Albuminuria and Estimated GFR as Risk Factors for Dementia in Midlife and Older Age: Findings From the ARIC Study.
    Scheppach JB; Coresh J; Wu A; Gottesman RF; Mosley TH; Knopman DS; Grams ME; Sharrett AR; Koton S
    Am J Kidney Dis; 2020 Dec; 76(6):775-783. PubMed ID: 32428540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of cystatin C- and creatinine-based estimated glomerular filtration rate equations depends on patient characteristics.
    Meeusen JW; Rule AD; Voskoboev N; Baumann NA; Lieske JC
    Clin Chem; 2015 Oct; 61(10):1265-72. PubMed ID: 26240296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shrunken Pore Syndrome: A New and More Powerful Phenotype of Renal Dysfunction Than Chronic Kidney Disease for Predicting Contrast-Associated Acute Kidney Injury.
    Zhang LW; Luo MQ; Xie XW; You ZB; Zeng JL; Lin MQ; Chen LC; Lin KY; Guo YS
    J Am Heart Assoc; 2023 Jan; 12(1):e027980. PubMed ID: 36565177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.